Register to get free articles
Want unlimited access? View Plans
Already have an account? Sign in
Walgreens Boots Alliance has announced the appointment of Steven Shulman to the company’s board of directors.
He joins the board as a director, effective 27 January 2022, and becomes the board’s eleventh member.
The firm said Shulman brings a “wealth” of healthcare management experience, as well as an “extensive” leadership background in emerging healthcare technologies. He currently serves on the boards at both VillageMD and CareCentrix, two companies in which WBA has recently taken a majority ownership interest.
Shulman will provide valuable insights and unique perspective to the WBA board as the company accelerates efforts to reimagine local healthcare delivery.
According to the firm, his prior healthcare leadership experience includes roles as chairman and CEO of Magellan Health Services. He previously served as chairman and CEO of Internet Healthcare Group and as chairman, president and CEO of Prudential Healthcare, where he was also director and president of the Pharmacy and Disease Management Group.
Stefano Pessina, executive chairman, Walgreens Boots Alliance, said: “Steven is a tremendous addition to our board of directors. His vast leadership experience and in-depth knowledge across the healthcare spectrum will be invaluable as we move into our next phase of being a market leader at the centre of community healthcare.”
Roz Brewer, CEO, Walgreens Boots Alliance, added: “We are very pleased to welcome Steven to our board. We look forward to benefiting from his industry expertise and viewpoints on the evolving healthcare landscape, as we continue to execute our consumer-centric healthcare strategy and drive long-term shareholder value.”
Shulman said: “I am honoured to join the Walgreens Boots Alliance board at an exciting and pivotal time, and look forward to working with the board and leadership team to further the great momentum they’ve built. I am condent WBA will make an even greater impact in the communities it serves, by improving access and health outcomes, while lowering the total cost of care.”
